載入...
Phase II study of bevacizumab and preoperative chemoradiation for esophageal adenocarcinoma
BACKGROUND: A standard-of-care for locally advanced esophageal and gastroesophageal junction (GEJ) adenocarcinoma is pre-operative chemoradiation. Elevated levels of vascular endothelial growth factor (VEGF) have been associated with worse outcomes following chemoradiation and anti-VEGF therapies ca...
Na minha lista:
| 發表在: | J Gastrointest Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
AME Publishing Company
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5177593/ https://ncbi.nlm.nih.gov/pubmed/28078107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2016.08.09 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|